Affiliation:
1. Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, UK
2. Royal Papworth Hospital NHS Foundation Trust, Cambridge CB2 0AY, UK
Abstract
Abstract
Surgical repair with implantation of a mitral annuloplasty ring is the gold standard treatment for mitral regurgitation. However, outcomes are variable and recurrent mitral regurgitation is not uncommon. A REshapeable Mitral Annuloplasty DevIce (REMADI) is proposed, which consists of a fully encapsulated low melting temperature alloy. The alloy is solid and rigid at body temperature and provides traction force to shape the annulus. When heated using a noncontact method, the alloy melts and the REMADI becomes malleable. The REMADI is engaged with the mitral valve annulus using anchors which automatically deploy upon contact. A passive beating porcine heart model was used to demonstrate the feasibility of the REMADI device, which was deployed, engaged, and used to reduce the diameter of the mitral valve annulus.
Subject
Biomedical Engineering,Medicine (miscellaneous)
Reference31 articles.
1. Epidemiology of Valvular Heart Disease in the Adult;Nat. Rev. Cardiol.,2011
2. Mitral Regurgitation;Lancet,2009
3. Transcatheter Mitral Valve Repair Therapies: Evolution, Status and Challenges;Ann. Biomed. Eng.,2016
4. Contribution of Ischemic Mitral Regurgitation to Congestive Heart Failure After Myocardial Infarction;J. Am. Coll. Cardiol.,2005